Indian agency objects to Mylan vaccine plant deal

An Indian agency has objected to Mylan's ($MYL) planned takeover of Agila Specialties because it would transfer another vaccine plant to a foreign owner. Indian officials fear the sale of the vaccine and oncology plants will limit the country's ability to supply affordable medicines to citizens. News